Ads
related to: camp4 therapeutics corp ipo schedule calendar date- Invest Early
Get Access into the Hottest Private
Tech Companies with Forge Global
- Buy/Sell Private Shares
The Largest Trading Platform
for the Private Market. Learn More.
- Forge Markets
The Largest Platform to Buy & Sell
Private Shares. Get Access Today.
- Private Market Index
View Up-To-Date Performance of
Pre-IPO Companies. Sign Up Today.
- FAQ for Investors
Learn How Forge Can Help You
Buy Shares in a Private Company
- Diversify Your Portfolio
Access Pre-IPO Tech Companies
& Explore Investment Opportunities
- Invest Early
workiva.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors [1] and usually also to retail (individual) investors. [2] An IPO is typically underwritten by one or more investment banks , who also arrange for the shares to be listed on one or more stock exchanges .
S&P MidCap 400 constituent LKQ Corp. (NASD:LKQ) will replace Airgas Inc. (NYSE:ARG) in the S&P 500. Air Liquide SA acquired Airgas. [256] May 12, 2016: TXRH: Texas Roadhouse: ALK: Alaska Air Group: S&P 500 constituent Western Digital Corp. (NASD:WDC) is acquiring SanDisk Corp. in a deal expected to be completed on or about that date pending ...
CAMBRIDGE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases, today announced the appointments of John Maraganore, Ph.D., and ...
Some 108 companies conducted their IPO in 2023 and raised $19.4 billion, according to Renaissance Capital. Those figures rose markedly from the 2022 doldrums of 71 IPOs and just $7.7 billion raised.
Kadmon Corporation (originally Kadmon Pharmaceuticals) is a biopharmaceutical company based in New York City. It also has operations in Warrendale , PA and Brighton, MA. The company was founded in 2009 by Samuel D. Waksal , [ 2 ] [ 3 ] founder and former CEO of ImClone Systems , a company now fully merged into Eli Lilly .
The U.S. IPO market is staging a strong comeback after two dismal years, thanks to a rally in the stock market and growing optimism of a possible interest rate cut this year. Rapport, backed by ...
ACT later changed its name to Ocata Therapeutics, and was acquired by Japanese pharmaceutical company Astellas Pharma for US$379M or $8.50 per share in February 2016. Prior that, West was founder, director, and chief scientific officer of Geron , for which he secured venture capital investment from Kleiner Perkins Caufield & Byers , Venrock [ 9 ...
Geron Corporation has sponsored human clinical trials of several potential anti-cancer products. Imetelstat (GRN163L) is a drug that targets telomerase. [13] In studies conducted at Johns Hopkins University, GRN163L was active against both CD138+ and CD138neg cancer stem cells and eliminated the colony forming potential of both by five weeks. [14]